v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 5,156,988 $ 7,813
General and administrative 1,363,464 143,863
Total operating expenses 6,520,452 151,677
Loss from operations (6,520,452) (151,677)
Interest income 282,579
Interest expense – related parties (50,785)
Other income 86,494
Net loss $ (6,202,164) $ (151,677)
Net loss per share, basic (in Dollars per share) $ (0.21) $ (0.2)
Net loss per share, diluted (in Dollars per share) $ (0.21) $ (0.2)
Basic weighted average shares outstanding (in Shares) 29,281,547 758,967
Diluted weighted average shares outstanding (in Shares) 29,281,547 758,967